科技日报北京9月13日电 （实习记者张佳欣）近日发表在《美国医学会内科杂志》和《美国医学会神经病学》上的两项研究，监测了78500名使用可穿戴跟踪器的成年人，证实每天走1万步是实现最佳健康效果的理想步数。 Rising star Aneet Padda, who captured hearts with her debut in Saiyaara, the highest-grossing love story in Indian cinema, is now preparing for a different kind of challenge: her college final-year exams. The 22-year-old actor, hailed as the biggest Gen Z face in the country, will be appearing for her B.A. (Hons.) Political Science finals in December and January.
A source close to the actor shared, “It’s inspiring how Aneet is managing everything so gracefully. Despite being a national sensation, she remains committed to her education. Her team is carefully structuring her schedule so she can focus on her exams while meeting professional commitments.;
Following her record-breaking debut, Aneet Padda has been handpicked by Dinesh Vijan to lead his much-anticipated film Shakti Shalini, part of the Maddock Horror Comedy Universe (MHCU). The film, which she signed at just 22, makes her the youngest actor ever to headline a franchise in Indian cinema.
An insider adds, “Aneet has an incredible work ethic. She has shown that success hasn’t changed her focus. Balancing college life and stardom isn’t easy, but she’s proving it’s possible with discipline and passion.”Released under Yash Raj Films, Saiyaara became an instant blockbuster and launched Aneet into superstardom alongside co-star Ahaan Panday. The film’s success has been compared to the iconic Kaho Naa... Pyaar Hai, making her debut one for the record books.Shakti Shalini is set to release on December 24, 2026, marking another milestone for Aneet, as the youngest actor to have a major Holiday release, a spot usually reserved for India’s biggest superstars.With her exams around the corner and a big-screen franchise waiting, Aneet Padda truly embodies the new-age Indian dream, balancing education, fame, and ambition with ease.ALos Read: Ayushmann Khurrana Welcomes Aneet Padda to MHCU As Shakti Shalini, Actress Responds。
B | 此外研究还发现，重要的不仅仅是走多少步，还有走多快。这两项研究也是迄今最大规模的关于行走步数对健康影响的研究。研究发现，每天走1万步可以降低患痴呆症、心脏病、癌症和死亡的风险。然而，更快的步速表现出的好处超过了所达到的步数。研究论文合著者、悉尼大学查尔斯·珀金斯中心和医学与健康学院研究员马修·艾哈迈迪博士说：“这一研究的结论是，为了保护健康，人们不仅可以把每天走1万步作为理想目标，还可以走得更快些。”研究人员称，每走2000步到1万步，过早死亡的风险就会降低8%—11%。
C | 心血管疾病和癌症发病率也有类似的关联。每天走的步数越多，患全因痴呆症的风险就越低。每天走3800步，风险就降低了25%。9800步是降低50%痴呆症风险的最佳步数。研究还表明，步频强度或较快的步速显示出与所有结果（痴呆症、心脏病、癌症和死亡）的有益关联，超过了每天的总步数带来的益处。这些发现可能会为基于步速的体育运动指南提供参考，并有助于制定旨在预防慢性病的有效公共卫生计划。
Current article:http://vkq7s4u.shaihanhuangwoshang.cyou/list_ss2/a3q.html
Published on:10:21:49
